Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Pictet North America Advisors SA

Pictet North America Advisors SA boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.9% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,049 shares of the medical equipment provider’s stock after buying an additional 144 shares during the period. Pictet North America Advisors SA’s holdings in Intuitive Surgical were worth $467,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the stock. Creekmur Asset Management LLC boosted its stake in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 42 shares in the last quarter. Delos Wealth Advisors LLC boosted its position in Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 57 shares during the period. LRI Investments LLC purchased a new position in Intuitive Surgical during the 1st quarter valued at about $30,000. Able Wealth Management LLC purchased a new position in Intuitive Surgical during the fourth quarter valued at approximately $28,000. Finally, MeadowBrook Investment Advisors LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter worth $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In related news, EVP Robert Desantis sold 584 shares of the stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $404.41, for a total transaction of $236,175.44. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,226,681.46. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Craig H. Barratt sold 2,496 shares of Intuitive Surgical stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $402.89, for a total value of $1,005,613.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 584 shares of the stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $404.41, for a total transaction of $236,175.44. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,226,681.46. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,309 shares of company stock worth $6,642,470. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG traded down $3.88 during trading on Friday, reaching $486.55. 1,155,222 shares of the company traded hands, compared to its average volume of 1,536,912. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $493.97. The company has a market cap of $172.58 billion, a price-to-earnings ratio of 87.82, a P/E/G ratio of 4.97 and a beta of 1.39. The stock’s 50 day moving average price is $449.52 and its two-hundred day moving average price is $411.24.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, beating the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. During the same quarter in the previous year, the firm earned $1.18 EPS. Intuitive Surgical’s quarterly revenue was up 14.5% on a year-over-year basis. Equities research analysts expect that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on ISRG shares. JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a research report on Friday, July 19th. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. BTIG Research upped their price objective on shares of Intuitive Surgical from $451.00 to $459.00 and gave the stock a “buy” rating in a report on Monday, July 15th. Piper Sandler boosted their price target on Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a research report on Friday, July 19th. Finally, Citigroup increased their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday. Six equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $444.70.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.